Trial intelligence / Profile preview

Bioequivalence study of Vortioxetine 10 mg film-coated tablet vs Brintellix 10 mg in healthy Thai volunteers under fasting

TCTR20250108005Phase 1Not yet recruiting

Sponsor
Bio-innova
Start
Jul 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, open-label trial of vortioxetine (2 arms), sponsored by Bio-innova. Planned start Jul 2025; status: not yet recruiting.

02

Drugs

vortioxetine

Beyond the preview

Go deeper on TCTR20250108005.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20250108005.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call